The American Academy of Pediatrics has reaffirmed its annual recommendation for influenza vaccination for children aged 6 months and older in their updated 2025-2026 policy statement. The statement simplifies antiviral treatment guidelines and expands eligibility for the recombinant influenza vaccine (RIV3) to children 9 years and older. Despite this, vaccination rates among U.S. children have declined, with a noted disparity in coverage among different demographics. Early vaccination is crucial, especially for high-risk populations, and further emphasis is placed on reducing racial and ethnic disparities in vaccine access.

Source: Pediatrics